Skip to content
SynXT Therapeutics

SynXT Therapeutics

The science of better health

Home
The Problem
Our Solution
Progress
Team
Contact Us

Our Data

Our Publications

H. Fan et al., Assessment of Phenylboronic Acid Nitrogen Mustards as Potent and Selective Drug Candidates for Triple-Negative Breast Cancer. ACS Pharmacol Transl Sci 4, 687-702 (2021).

Ali, T et al. Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment. Cancers 2024, 16, 2171.

Ali, T et al. Exploiting Vitamin C as a Prooxidant to Activate Ros-Responsive Prodrugs for Potent and Selective Tumor Killing. Redox Biology. 2026 Sep; 95:104229.

Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killingDownload
SynXT Therapeutics

SynXT Therapeutics

About

  • Team
  • The Problem
  • Our Solution

Social

  • Instagram
  • Contact Us

Loading Comments...
  • Subscribe Subscribed
    SynXT Therapeutics

    Have a WordPress.com account? Log in now.

  • SynXT Therapeutics
    Copy shortlinkView post in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar